🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 10 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/04/1994 | 49,83 | 49,83 | 45,85 | 46,79 | -3,85% | 7,98% | 4.462 |
| 18/04/1994 | 48,66 | 49,83 | 48,66 | 48,66 | -5,45% | 2,40% | 908 |
| 15/04/1994 | 48,66 | 51,47 | 48,66 | 51,47 | +3,29% | 5,77% | 14.347 |
| 14/04/1994 | 48,66 | 51,47 | 48,66 | 49,83 | -2,29% | 5,77% | 1.576 |
| 13/04/1994 | 48,66 | 51,00 | 48,66 | 51,00 | +4,81% | 4,81% | 1.763 |
| 12/04/1994 | 48,66 | 48,66 | 48,66 | 48,66 | +0,00% | 0,00% | 0 |
| 11/04/1994 | 51,47 | 51,47 | 48,66 | 48,66 | +0,00% | 5,45% | 1.496 |
| 08/04/1994 | 48,66 | 51,47 | 48,66 | 48,66 | -5,45% | 5,77% | 4.488 |
| 07/04/1994 | 51,47 | 51,47 | 49,59 | 51,47 | +0,92% | 3,64% | 2.298 |
| 06/04/1994 | 51,00 | 51,00 | 50,53 | 51,00 | -0,91% | 0,92% | 2.805 |
| 05/04/1994 | 49,59 | 51,47 | 49,59 | 51,47 | +10,00% | 3,77% | 4.916 |
| 04/04/1994 | 46,79 | 49,59 | 46,79 | 46,79 | -1,96% | 6,00% | 2.618 |
| 31/03/1994 | 47,72 | 50,53 | 47,72 | 47,72 | +0,00% | 5,88% | 1.363 |
| 30/03/1994 | 47,72 | 50,53 | 47,72 | 47,72 | -4,67% | 5,88% | 1.817 |
| 29/03/1994 | 52,40 | 52,40 | 49,59 | 50,06 | +0,00% | 5,36% | 3.099 |
| 28/03/1994 | 49,59 | 52,40 | 49,59 | 50,06 | -4,46% | 5,66% | 2.057 |
| 25/03/1994 | 49,59 | 52,40 | 49,59 | 52,40 | +1,82% | 5,66% | 534 |
| 24/03/1994 | 49,59 | 52,40 | 49,59 | 51,47 | +5,77% | 5,66% | 534 |
| 23/03/1994 | 48,66 | 50,06 | 48,66 | 48,66 | -4,59% | 2,88% | 2.725 |
| 22/03/1994 | 50,53 | 51,00 | 48,66 | 51,00 | +2,83% | 4,63% | 4.836 |
| 21/03/1994 | 51,47 | 51,47 | 49,59 | 49,59 | -3,64% | 3,64% | 935 |
| 18/03/1994 | 48,66 | 51,47 | 48,66 | 51,47 | +1,85% | 5,77% | 508 |
| 17/03/1994 | 48,66 | 50,53 | 48,66 | 50,53 | -1,82% | 3,85% | 3.313 |
| 16/03/1994 | 51,47 | 51,47 | 48,66 | 51,47 | +0,92% | 5,45% | 748 |
| 15/03/1994 | 50,53 | 51,00 | 48,66 | 51,00 | -0,91% | 4,63% | 1.469 |
| 14/03/1994 | 48,66 | 51,47 | 48,66 | 51,47 | +0,00% | 5,77% | 1.817 |
| 11/03/1994 | 47,72 | 51,47 | 47,72 | 51,47 | +1,85% | 7,84% | 908 |
| 10/03/1994 | 47,72 | 50,53 | 47,72 | 50,53 | +1,89% | 5,88% | 1.015 |
| 09/03/1994 | 47,72 | 49,59 | 47,72 | 49,59 | +3,92% | 3,92% | 1.122 |
| 08/03/1994 | 46,79 | 50,53 | 46,79 | 47,72 | +2,00% | 8,00% | 1.443 |